EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Herpes Zoster and Post-Herpetic Neuralgia—Diagnosis, Treatment, and Vaccination Strategies

Delwyn Zhi Jie Lim iD, Hong Liang Tey iD, Brenda Mae Alferez Salada, Jolene Ee Ling Oon, Ee-Jin Darren Seah, Nisha Suyien Chandran, Jiun Yit Pan

Pathogens · 17.07.2024 · 13 (7) · 596

DOI: 10.3390/pathogens13070596 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 17.07.2024. Verfasst von Delwyn Zhi Jie Lim und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Skin Centre, Singapore 308205, Singapore. Hauptthemen laut MEDLINE: Herpes Zoster, Neuralgia, Postherpetic, Herpes Zoster Vaccine, Herpesvirus 3, Human. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GlaxoSmithKline Singapore, GlaxoSmithKline plc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Herpes zoster is caused by the reactivation of latent varicella infection within the sensory ganglia, caused by the varicella-zoster virus (VZV). The disease is classically characterized by a painful unilateral vesicular eruption. Complications of the disease include herpes zoster ophthalmicus, Ramsay Hunt syndrome, acute retinal necrosis, and post-herpetic neuralgia. In this paper, we discuss the epidemiology, pathogenesis, clinical features, diagnosis, management, and vaccination strategies of herpes zoster and post-herpetic neuralgia.

Method

This paper was developed with input from specialists from Singapore’s public sectors—dermatologists, family physicians, and infectious diseases specialists.

Results

The diagnosis of herpes zoster is clinical and can be aided with laboratory investigations. Early initiation of antivirals, within 72 h of onset, can reduce the severity and duration of the condition and decrease the intensity of pain. In patients with a high risk of post-herpetic neuralgia, early initiation of anticonvulsants or tricyclic antidepressants can be considered. Herpes zoster is highly preventable, with the advent of the recombinant zoster vaccine (RZV) providing an overall vaccine efficacy of 97.2%. Procedures such as epidural blocks and subcutaneous or intracutaneous injections of local anesthetics and steroids can be considered for patients with a high risk of post-herpetic neuralgia to reduce its incidence.

Conclusion

This article serves as a guideline for clinicians in the diagnosis, investigations, management, and prevention of herpes zoster. With the majority of adults in Singapore currently at risk of developing herpes zoster due to varicella immunization being only introduced in 2020, it is important for clinicians to recognize and manage herpes zoster appropriately.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpes ZosterNeuralgia, PostherpeticHerpes Zoster VaccineHerpesvirus 3, HumanAntiviral AgentsHumansSingaporeVaccination

Stichwörter der Autor:innen

herpes zosterpost-herpetic neuralgia

Substanzen

Herpes Zoster VaccineAntiviral Agents

Autor:innen und Institutionen

  • National Skin Centre, Singapore 308205, Singapore.
  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 637371, Singapore.
  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore 169857, Singapore.
  • Division of Infectious Diseases, University Medicine Cluster, National University Health System, Singapore 119228, Singapore.
  • National Healthcare Group Polyclinics, Singapore 308433, Singapore.
  • Division of Dermatology, Department of Medicine, National University Hospital, Singapore 119074, Singapore.

ORCID-Profile: Delwyn Zhi Jie Lim, Hong Liang Tey

Förderung

  • GlaxoSmithKline Singapore
  • GlaxoSmithKline plc

Zitieren

APA

Lim, D. Z. J., Tey, H. L., Salada, B. M. A., Oon, J. E. L., Seah, E. D., Chandran, N. S., & Pan, J. Y. (2024). Herpes Zoster and Post-Herpetic Neuralgia—Diagnosis, Treatment, and Vaccination Strategies. Pathogens, 13(7), 596. https://doi.org/10.3390/pathogens13070596

Vancouver

Lim DZJ, Tey HL, Salada BMA, Oon JEL, Seah ED, Chandran NS, et al. Herpes Zoster and Post-Herpetic Neuralgia—Diagnosis, Treatment, and Vaccination Strategies. Pathogens. 2024;13(7):596. doi:10.3390/pathogens13070596

BibTeX
@article{Lim2024,
  author = {Lim, Delwyn Zhi Jie and Tey, Hong Liang and Salada, Brenda Mae Alferez and Oon, Jolene Ee Ling and Seah, Ee-Jin Darren and Chandran, Nisha Suyien and Pan, Jiun Yit},
  title = {Herpes Zoster and Post-Herpetic Neuralgia—Diagnosis, Treatment, and Vaccination Strategies},
  journal = {Pathogens},
  year = {2024},
  volume = {13},
  number = {7},
  pages = {596},
  doi = {10.3390/pathogens13070596}
}
Kostenlos starten →